COOT Aus Oilseeds revenue jumps 161 to 337M in Q3 shares climb 2 despite ongoing losses How Scorpio STNG thinks about risk management Scorpio posts 07 EPS beat vs consensus estimates IART Integra posts narrow Q4 2025 EPS beat against consensus estimates shares trade higher on investor optimism What CapSouthwest CSWC is investing to grow Q1 2026 EPS Tops Views Singapore Airlines Adjusts Fares Amid Rising Fuel Costs Opts for Partial Absorption Subramanian Swamy Calls for Ban on Pakistan Cement Imports Citing National Security Risks Surge in Gas Prices Disproportionately Pressures LowerIncome Households New York Fed Study Suggests Jim Cramer Recommends Buying Pullbacks Amid Market Rotation Salesforce and ServiceNow Surge University of Manchester Expands Work Placements to All Undergraduates Setting New Education Standard Understanding Debt Settlement How It Works and Potential Costs Americans Face Stubborn Inflation Pressures as Memorial Day Weekend Spending Rises Travel Recreation and Food Lead Price Hikes ICICI Securities Analyst Recommends Tata Motors and BHEL as Markets Rally on Crude Price Drop OpenAI Moves Toward IPO Fueling AI Market Competition Lenovo Shares Surge Over 15 as Record Earnings Highlight AI Revenue Growth 51Talk COE Q3 2025 Earnings Net Loss Widens as Stock Declines Amid Quiet Quarter Trane Technologies TT Q1 2026 Earnings EPS Beats Estimates as Operational Strength Drives Confidence MDV Q1 2026 Earnings Industrial REIT Reports Deep Earnings Miss as Losses Sharply Exceed Estimates TNYA Q1 2026 Earnings Modest EPS Miss but Stock Gains on Operational Focus USFD Q1 2026 Earnings EPS Misses Estimates but Stock Gains Amid Operational Improvements TAK Q1 2026 Earnings SmallerThanExpected Loss Fails to Lift Shares ONBPP Q1 2026 Earnings Slight EPS Miss Flat Stock Reaction for Old National Bancorp Preferred RBKB Q1 2026 Earnings EPS of 020 Reported Amid Stock Decline NCR Atleos NATL Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Lower IMMP Q1 2026 Earnings Earnings Miss Estimates as Clinical Expenses Weigh on Results CRCT Q1 2026 Earnings EPS Surges 145 Above Estimates Stock Slips Oppenheimer Maintains Outperform Rating on Gain Therapeutics Signaling Continued Confidence COCH Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress Though Revenue Absence Raises Questions